Pharmaceutical company GlaxoSmithKline announced it is temporarily discontinuing two types of Excedrin migraine medications.
“Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs,” the company said in a statement to CNN on Wednesday.
The company has reassured consumers that pulling the products off the shelves and suspending further production and distribution of the two products is a precautionary measure. Currently, the company says it does not think the recalled items pose a safety risk to its users.
While the two popular products will be unavailable for purchase, other items including Excedrin PM Headache and Excedrin Tension Headache will still be accessible at local drugstores and pharmacies.
Take a look at the biggest retailers that filed for bankruptcy in 2019: